|1.||Storm, Gert: 13 articles (01/2013 - 07/2003)|
|2.||Schiffelers, Raymond M: 7 articles (05/2011 - 02/2005)|
|3.||Metselaar, Josbert M: 6 articles (07/2008 - 07/2003)|
|4.||Rajaraman, Revathi: 5 articles (02/2014 - 02/2012)|
|5.||Ray, Kathryn J: 5 articles (02/2014 - 02/2012)|
|6.||Zegans, Michael E: 5 articles (02/2014 - 02/2012)|
|7.||Lietman, Thomas M: 5 articles (02/2014 - 02/2012)|
|8.||Acharya, Nisha R: 5 articles (02/2014 - 02/2012)|
|9.||Oldenburg, Catherine E: 5 articles (02/2014 - 02/2012)|
|10.||Srinivasan, Muthiah: 5 articles (02/2014 - 02/2012)|
09/20/2011 - "In a subsequent dose-response study, we found that a single dose of 1mg/kg liposomal prednisolone phosphate (PLP) was still equally effective in suppressing joint inflammation as 4 repeated once-daily injections of 10mg/kg free PLP. "
04/01/2010 - "The results concluded that prednisolone acetate 1.0 per cent ophthalmic suspension is more effective than prednisolone phosphate 1.0 per cent ophthalmic solution in suppressing corneal inflammation."
03/01/1995 - "Both prednisolone acetate and prednisolone phosphate reduced ocular inflammation (as determined by SLE), compared with no treatment (P < or = 0.036); the phosphate was more effective (P = 0.005). "
03/01/1990 - "Various doses of a new topical nonsteroidal anti-inflammatory agent, diclofenac sodium, were tested against prednisolone sodium phosphate in a randomized double-masked study to determine comparative efficacy and safety regarding the reduction of postsurgical ocular inflammation. "
01/01/1980 - "Clobetasone butyrate, a new corticosteroid with a high topical activity, has been compared with prednisolone phosphate and a placebo in the treatment of inflammation following cataract extraction. "
12/01/2012 - "intervention/observation procedure: Topical prednisolone phosphate 1% or placebo and clinical course of Nocardia keratitis. "
02/01/2009 - "In this single centre, double-masked clinical trial, 42 patients with culture-confirmed bacterial keratitis at Aravind Eye Hospital in India were randomised to receive either topical prednisolone phosphate or placebo. "
01/01/1989 - "Topical deoxycytidine 10(-4) M and 1% prednisolone phosphate, given 12 hours prior to the start of antileukemic therapy, were effective in reducing symptoms and signs of keratitis; both were better than historical placebo-treated eyes. "
07/01/1990 - "In rabbit models of untreated Pseudomonas keratitis and pneumococcal keratitis, topical 1% prednisolone phosphate, 0.03% flurbiprofen sodium, and vehicle were applied hourly. "
02/01/2014 - "This multicenter trial compared 1.0% prednisolone sodium phosphate to placebo in the treatment of bacterial keratitis among 500 patients with culture-positive ulcers receiving 48 hours of moxifloxacin before randomization. "
11/01/2004 - "Intrarectal administration of 5-aminosalicylic acid or sodium prednisolone phosphate resulted in a significant improvement in the colitis. "
08/01/2001 - "Effects of 5-aminosalicylic acid and sodium prednisolone phosphate were investigated by intrarectal administration in this colitis model. "
|4.||Asthma (Bronchial Asthma)
06/01/1975 - "A single injection of 40 mg prednisolone phosphate was given to 10 patients with chronic bronchial asthma. "
09/01/2007 - "To evaluate the efficacy of prednisolone sodium phosphate oral solution plus inhaled procaterol in the treatment of acute asthma in children. "
09/01/2007 - "Prednisolone sodium phosphate oral solution plus inhaled procaterol is as efficacious as prednisolone tablets plus inhaled procaterol in the management of acute asthma in children."
05/01/2011 - "In this study, we determined the anti-angiogenic activity of a single dose of liposomal prednisolone phosphate (PLP-L), by monitoring tumor vascular function and viability over a period of one week. "
02/01/2005 - "Prednisolone phosphate in the free form was completely ineffective at this low-frequency treatment schedule, even when administered at a dose of 50 mg/kg. In vitro studies did not show an inhibitory effect of prednisolone (phosphate) on tumor cell, nor on endothelial cell proliferation. "
08/01/2008 - "As positive control, the same experiments were conducted with LCL-encapsulated prednisolone phosphate (LCL-PLP), a tumor-targeted formulation with known strong anti-angiogenic/anti-inflammatory effects on TAM. "
02/01/2008 - "Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue."
02/01/2005 - "Histologic evaluation revealed that liposomal prednisolone phosphate-treated tumors contained a center with areas of picnotic/necrotic cells, which were not apparent in untreated tumors or tumors treated with the free drug. "
|9.||Diclofenac (SR 38)